Vaccine could cure more than 90% percent of cancers

The vaccine targets a molecule present in 90 percent of all cancers and it is the first time that is tested in humans.

The results of the study in patients with cancer of the blood, found to have a greater immunity to the disease after receiving the vaccine. Three of the seven patients who completed treatment are now free of the disease.

The therapeutic vaccine is designed to be administered to patients to help their bodies fight most cancers, is also aimed to preventing the disease.

Researchers believe the vaccine could also deal with breast, prostate, pancreas, bowel and ovarian cancer.

Even tumors resistant to treatments with the best drugs on the market, including Herceptin ‘wonder drug’ for breast cancer, may be susceptible to the vaccine.

If all goes well, the vaccine called ‘ImMucin’ could be on the market in 2020.

Instead of attacking cancer cells, like many drugs, new treatment harnesses the power of the immune system to fight tumors.